18f-deoxyglucose (fdg) (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 57 | 特発性拡張型心筋症 | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02078141 (ClinicalTrials.gov) | June 2014 | 21/2/2014 | 18F-deoxyglucose (FDG) PET-CMD | Monocentric, Prospective, Uncontrolled Pilot Study of Extra Cardiomyocytary Fixation Profile in 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography in Patients With Dilated Cardiomyopathy. | Patients With Idiopathic Dilated Cardiomyopathy | Drug: 18F-deoxyglucose (FDG) | Nantes University Hospital | NULL | Unknown status | 18 Years | N/A | All | 30 | N/A | France |